The Impact of Tobacco Smoking on Treatment for Comorbid Depression and Alcohol Misuse

详细信息    查看全文

• 作者：Frances Kay-Lambkin (1) (2) (5)
  Sarah Edwards (2)
  Amanda Baker (2)
  David Kavanagh (3)
  Brian Kelly (2)
  Jenny Bowman (4)
  Terry Lewin (2)
  
• 关键词：Tobacco ; Depression ; Alcohol ; related disorders ; Therapy
• 刊名：International Journal of Mental Health and Addiction
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：11
• 期：6
• 页码：619-633
• 全文大小：
• 作者单位：Frances Kay-Lambkin (1) (2) (5)
  Sarah Edwards (2)
  Amanda Baker (2)
  David Kavanagh (3)
  Brian Kelly (2)
  Jenny Bowman (4)
  Terry Lewin (2)
  
  1. National Drug and Alcohol Research Centre, University of New South Wales, Randwick, New South Wales, Australia
  2. Centre for Translational Neuroscience and Mental Health, University of Newcastle, Callaghan, New South Wales, Australia
  5. Calvary Mater Hospital, Level 5, McAuley Centre, Waratah, NSW, 2289, Australia
  3. Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Qld, Australia
  4. School of Psychology, University of Newcastle, Callaghan, New South Wales, Australia
  
• ISSN：1557-1882

文摘

Tobacco use is a major public health concern, and is associated with a number of mental illnesses as well as increased alcohol/other drug (AOD). Research into treatment for individuals experiencing such comorbidities is limited. Participants (n=447) were those enrolled in the Depression and Alcohol Integrated and Single-focused Interventions project (Baker et al. 2010), and the Self Help for Alcohol/other drugs and DEpression project (Kay-Lambkin et al. Medical Journal of Australia 195:S4450, 2011a, Journal of Medical Internet Research 13(1):e11p11, b), who reported current depression and hazardous alcohol use at entry to the study. Smoking cessation was not targeted in, nor a goal of, treatment. After controlling for socioeconomic variables, tobacco use was not associated with higher levels of depressive symptoms at baseline; however heavy smokers (30+ cigarettes per day) consumed significantly more alcohol at baseline than did non-smokers (13 vs. 9 standard drinks per day). Baseline smoking severity did not impact on depression or alcohol use outcomes over a 12-month period. Reductions in tobacco use between baseline and 3-month follow-up were significantly associated with reductions in depression and alcohol consumption over the same time period. The study results suggest that tobacco use does not interfere with treatment for depression and alcohol use problems, and adds weight to the idea of considering specific treatment for tobacco use in the context of treatment for alcohol/other drug use.